Page last updated: 2024-10-31

neostigmine and Neurotic Disorders

neostigmine has been researched along with Neurotic Disorders in 1 studies

Neostigmine: A cholinesterase inhibitor used in the treatment of myasthenia gravis and to reverse the effects of muscle relaxants such as gallamine and tubocurarine. Neostigmine, unlike PHYSOSTIGMINE, does not cross the blood-brain barrier.
neostigmine : A quaternary ammonium ion comprising an anilinium ion core having three methyl substituents on the aniline nitrogen, and a 3-[(dimethylcarbamoyl)oxy] substituent at position 3. It is a parasympathomimetic which acts as a reversible acetylcholinesterase inhibitor.

Neurotic Disorders: Disorders in which the symptoms are distressing to the individual and recognized by him or her as being unacceptable. Social relationships may be greatly affected but usually remain within acceptable limits. The disturbance is relatively enduring or recurrent without treatment.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19901 (100.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
PRESWICK, G1
HENDERSON, AS1

Other Studies

1 other study available for neostigmine and Neurotic Disorders

ArticleYear
MYASTHENIA AND THE "ASTHENIC" SYNDROME.
    The Medical journal of Australia, 1965, Mar-06, Volume: 1, Issue:10

    Topics: Diagnosis, Differential; Drug Therapy; Humans; Hysteria; Mental Disorders; Muscular Diseases; Myasth

1965